Clinical Scorecard: Effects of Direct-to-Consumer Telemedicine Visits on Follow-Up Care, Episode Costs, and Antibiotic Use for Upper Respiratory Tract Infections in Sweden: An Observational Study

At a Glance

Key Highlights

• The study compares DTC telemedicine and in-person URTI care episodes for follow-up consultations, episode costs, and antibiotic prescribing.
• The analysis uses patient-level information from urban and rural areas of Sweden and includes patients aged 2 years or older.
• The article describes URTIs as frequent reasons for primary-care consultations; most are self-limiting and do not require antibiotics.
• Prior research on telemedicine and antibiotic prescribing has reported higher, comparable, or lower rates than in-person care.

Guideline-Based Recommendations

Diagnosis

Management

Monitoring & Follow-up

Risks

Patient & Prescribing Data

Patients aged 2 years or older with URTI care episodes in Sweden.

Antibiotic prescribing is one of the study’s comparison outcomes. The supplied source excerpt does not provide prescribing results or treatment recommendations.

Clinical Best Practices

• The article states that most URTIs are self-limiting and do not require antibiotic therapy.
• The study evaluates follow-up consultations, episode costs, and antibiotic prescribing after DTC telemedicine versus in-person care.

Related Resources & Content